Yubo International Biotech Ltd. engages in the supply of products that process, store, and administer therapeutic doses of endometrial stem cells for the treatment of disease and injuries. The company is headquartered in Beijing, Beijing and currently employs 18 full-time employees. The firm focuses on the research and development and application of endometrial stem cells and offers its products and services under the brand VIVCELL. The Company’s product offerings include healthcare products for respiratory system, skincare products, hair care products, healthy beverages and male and female personal care products. The firm also offers stem cell related services including cell testing and health management consulting services.
Follow-Up Questions
Who is the CEO of Yubo International Biotech Ltd?
Mr. Jun Wang is the President of Yubo International Biotech Ltd, joining the firm since 2020.
What is the price performance of YBGJ stock?
The current price of YBGJ is $0.0134, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Yubo International Biotech Ltd?
Yubo International Biotech Ltd belongs to N/A industry and the sector is N/A
What is Yubo International Biotech Ltd market cap?
Yubo International Biotech Ltd's current market cap is $2.2M
